Lundbeck
J. Paul Kilburn possesses extensive experience in the pharmaceutical industry, serving in various leadership roles such as Senior Director and Head of Medicinal Chemistry and Translational DMPK, Director and Head of Medicinal Chemistry, and Head of Department at Lundbeck. Prior to this, J. Paul Kilburn worked as a Research Scientist at Novo Nordisk and held postdoctoral research positions at the University of York. J. Paul Kilburn began a career in chemistry with positions at AVOCADO RESEARCH CHEMICALS LIMITED and LANCASTER SYNTHESIS LIMITED. Educational credentials include a BSc in Applied Chemistry from The University of Huddersfield and a PhD in Organic Synthesis from The Open University.
Lundbeck
42 followers
Lundbeck is a global pharmaceutical company highly committed to improving the quality of life of people living with psychiatric and neurological disorders. For this purpose, Lundbeck is engaged in the research, development, production, marketing and sale of pharmaceuticals across the world. The company’s products are targeted at disease areas such as depression, schizophrenia, Parkinson’s disease and Alzheimer’s disease.